# Brain Derived Neurotrophic Factor as a Predictor of Response to Treatment in Bipolar Depression and Mania: 16-weeks Follow-up With Quetiapine XR

> **NCT00879307** · PHASE3 · UNKNOWN · sponsor: **Hospital de Clinicas de Porto Alegre** · enrollment: 100 (estimated)

## Conditions studied

- BIPOLAR DISORDER

## Interventions

- **DRUG:** quetiapine

## Key facts

- **NCT ID:** NCT00879307
- **Lead sponsor:** Hospital de Clinicas de Porto Alegre
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-03
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2011-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00879307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00879307, "Brain Derived Neurotrophic Factor as a Predictor of Response to Treatment in Bipolar Depression and Mania: 16-weeks Follow-up With Quetiapine XR". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00879307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*